GFM
OLMA icon

GF Fund Management’s Olema Pharmaceuticals OLMA Stock Holding History

GF Fund Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.2K Sell
1,698
-69
-4% -$924 ﹤0.01% 478
2026
Q1 		$26.3K Buy
1,767
+221
+14% +$4.92K ﹤0.01% 469
2025
Q4 		$38.6K Buy
1,546
+69
+5% +$1.23K ﹤0.01% 428
2025
Q3 		$14.5K Buy
1,477
+55
+4% +$330 ﹤0.01% 524
2025
Q2 		$6.06K Hold
1,422
– – ﹤0.01% 616
2025
Q1 		$5.35K Buy
1,422
+219
+18% +$1.1K ﹤0.01% 620
2024
Q4 		$7.01K Buy
+1,203
New +$12K ﹤0.01% 586

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GF Fund Management's OLMA Position: Q2 2026 in Review

GF Fund Management reduced its Olema Pharmaceuticals (OLMA) stake by 3.9% in Q2 2026, selling an estimated $924 and leaving 1,698 shares worth $21.2K. The position accounts for ﹤0.01% of the portfolio, ranked #478.

GF Fund Management first reported a position in OLMA in Q4 2024 and has held it in 7 quarters since. The position peaked at $38.6K in Q4 2025. 186 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • GF Fund Management held 1,698 shares of Olema Pharmaceuticals worth $21.2K as of Q2 2026.
  • GF Fund Management sold 69 Olema Pharmaceuticals shares in Q2 2026, an estimated $924.
  • Olema Pharmaceuticals made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #478 holding.
  • GF Fund Management first reported a position in Olema Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • GF Fund Management's Olema Pharmaceuticals position peaked at $38.6K in Q4 2025.
  • 186 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.